Inclisiran for the Treatment of Cardiovascular Disease: A Short Review on the Emerging Data and Therapeutic Potential

por Kosmas, Constantine E, Muñoz Estrella, Alba, Skavdis, Andreas, Peña Genao, Edilberto, Martinez, Ian, Guzman, Eliscer
Publicado 2020

Safety and Tolerability of PCSK9 Inhibitors: Current Insights

por Kosmas, Constantine E, Skavdis, Andreas, Sourlas, Andreas, Papakonstantinou, Evangelia J, Peña Genao, Edilberto, Echavarria Uceta, Rogers, Guzman, Eliscer
Publicado 2020

Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia

por Kosmas, Constantine E, Bousvarou, Maria D, Sourlas, Andreas, Papakonstantinou, Evangelia J, Peña Genao, Edilberto, Echavarria Uceta, Rogers, Guzman, Eliscer
Publicado 2022

The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease

por Kosmas, Constantine E., Rodriguez Polanco, Shanna, Bousvarou, Maria D., Papakonstantinou, Evangelia J., Peña Genao, Edilberto, Guzman, Eliscer, Kostara, Christina E.
Publicado 2023